tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market

Rallybio (RLYB) Income Statement

Compare
318 Followers

Rallybio Income Statement

Last quarter (Q3 2024), Rallybio's total revenue was $299.00K, an increase of Infinity% from the same quarter last year. In Q3, Rallybio's net income was $-11.47M. See Rallybio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -150.00K$ -167.00K$ -109.00K$ -62.03K$ -26.34K
Operating Expenses
$ 78.93M$ 67.88M$ 45.65M$ 25.30M$ 17.64M
Depreciation and Amortization
$ 150.00K$ 167.00K$ 109.00K$ 62.03K$ 26.34K
EBITDA
$ -72.37M$ -65.41M$ -45.39M$ -24.83M$ -17.39M
Operating Income
$ -78.93M$ -67.88M$ -45.65M$ -25.30M$ -17.64M
Other Income/Expenses
$ 4.37M$ 2.31M$ 140.00K$ 363.00K$ 182.00K
Pretax Income
$ -74.56M$ -65.58M$ -45.51M$ -24.94M$ -17.46M
Net Income
$ -74.56M$ -66.49M$ -47.01M$ -24.93M$ -17.63M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.84$ -2.09$ -1.46$ -0.78$ -0.55
Diluted EPS
$ -1.84$ -2.09$ -1.46$ -0.78$ -0.55
Weighted Average Shares Outstanding
40.45M 31.82M 32.13M 32.13M 32.13M
Weighted Average Shares Outstanding (Diluted)
40.45M 31.82M 32.13M 32.13M 32.13M
Currency in USD

Rallybio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis